C4 Therapeutics
CCCC
#8153
Rank
A$0.49 B
Marketcap
A$3.75
Share price
1.64%
Change (1 day)
-0.83%
Change (1 year)

Earnings for C4 Therapeutics (CCCC)

Earnings in 2026 (TTM): -A$0.15 Billion

According to C4 Therapeutics's latest financial reports the company's current earnings are A$32.27 Million. In 2025 the company made an earning of -A$0.16 Billion, an increase over its 2024 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for C4 Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.15 Billion-6.03%
2025 -A$0.16 Billion-8.27%
2024 -A$0.18 Billion-12.27%
2023 -A$0.2 Billion3.08%
2022 -A$0.2 Billion54.08%
2021 -A$0.13 Billion25.35%
2020 -A$98.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 53.15%๐Ÿ‡บ๐Ÿ‡ธ USA